Výsledky vyhledávání - "Paula Grouleff"

Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) with Erlotinib (OSI-774)

Autor: Bert L. Lum, Daniel A. Laheru, Theresa Rogers, N. Senzer, Wells A. Messersmith, Manuel Hidalgo, Sean K. Kelley, David Ramies, Paula Grouleff, Ross C. Donehower

Publikováno v: Clinical Cancer Research. 10:6522-6527

Purpose: This phase I study was conducted to establish the dose-limiting toxicities and maximum-tolerated dose of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in combination with FOLFIRI, a standard regimen of irinot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::99ff6a2e614e44d43a4bc956e25e1769
https://doi.org/10.1158/1078-0432.ccr-04-0746

Zobrazit plný text záznamu

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities

Autor: Wells A, Messersmith, Daniel A, Laheru, Neil N, Senzer, Ross C, Donehower, Paula, Grouleff, Theresa, Rogers, Sean K, Kelley, David A, Ramies, Bert L, Lum, Manuel, Hidalgo

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 10(19)

This phase I study was conducted to establish the dose-limiting toxicities and maximum-tolerated dose of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in combination with FOLFIRI, a standard regimen of irinotecan, leu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::03a6c6353b82cd40be41c743fafcf222
https://pubmed.ncbi.nlm.nih.gov/15475439

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání